Italia markets closed

FTSE MIB
33.629,21
-107,19(-0,32%)
Dow Jones
38.675,68
+450,02(+1,18%)
Nasdaq
16.156,33
+315,37(+1,99%)
Nikkei 225
38.236,07
-37,98(-0,10%)
Petrolio
77,99
-0,96(-1,22%)
Bitcoin EUR
58.878,14
+1.471,92(+2,56%)

Alcon Inc. (ALC)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.

Aggiungi a watchlist

79,57

+1,15

(+1,47%)

Alla chiusura: 04:00PM EDT

78,03

-1,54

(-1,94%)

Dopo ore:

04:06PM EDT

I prezzi di scambio non provengono da tutti i mercati

Capitalizzazione	39,247B
Beta (5 anni mensile)	0,67
Rapporto PE (ttm)	40,60
EPS (ttm)	1,96
Prossima data utili	14 mag 2024
Rendimento e dividendo (futuro)	0,27 (0,34%)
Data ex dividendo	10 mag 2024
Stima target 1A	91,67

Tutte

GlobeNewswire
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loanCHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company” Nasdaq: LFCR), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a broad set of agreements with its long-term customer, Alcon (SIX/NYSE: ALC), which provides for the repayment of the Company’s